201 related articles for article (PubMed ID: 19357119)
1. Conotruncal heart defects in three patients with congenital disorder of glycosylation type Ia (CDG Ia).
Romano S; Bajolle F; Valayannopoulos V; Lyonnet S; Colomb V; de Baracé C; Vouhe P; Pouard P; Vuillaumier-Barrot S; Dupré T; de Keyzer Y; Sidi D; Seta N; Bonnet D; de Lonlay P
J Med Genet; 2009 Apr; 46(4):287-8. PubMed ID: 19357119
[No Abstract] [Full Text] [Related]
2. Increased recurrence risk in congenital disorders of glycosylation type Ia (CDG-Ia) due to a transmission ratio distortion.
Schollen E; Kjaergaard S; Martinsson T; Vuillaumier-Barrot S; Dunoe M; Keldermans L; Seta N; Matthijs G
J Med Genet; 2004 Nov; 41(11):877-80. PubMed ID: 15520415
[No Abstract] [Full Text] [Related]
3. Prenatal diagnosis for CDG Ia based on post-mortem molecular study of Guthrie card.
Nogueira C; Quelhas D; Vilarinho L
Mol Genet Metab; 2006 Apr; 87(4):379. PubMed ID: 16343971
[No Abstract] [Full Text] [Related]
4. Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia).
Schollen E; Kjaergaard S; Legius E; Schwartz M; Matthijs G
Eur J Hum Genet; 2000 May; 8(5):367-71. PubMed ID: 10854097
[TBL] [Abstract][Full Text] [Related]
5. Congenital disorder of glycosylation type 1a: three siblings with a mild neurological phenotype.
Coman D; McGill J; MacDonald R; Morris D; Klingberg S; Jaeken J; Appleton D
J Clin Neurosci; 2007 Jul; 14(7):668-72. PubMed ID: 17451957
[TBL] [Abstract][Full Text] [Related]
6. CDG type Ia and congenital cytomegalovirus infection: two coexisting conditions.
Jamroz E; Adamek D; Paprocka J; Adamowicz M; Marszał E; Wevers RA
J Child Neurol; 2009 Jan; 24(1):13-8. PubMed ID: 19168813
[TBL] [Abstract][Full Text] [Related]
7. Congenital disorder of glycosylation type Ia: a clinicopathological report of a newborn infant with cerebellar pathology.
Aronica E; van Kempen AA; van der Heide M; Poll-The BT; van Slooten HJ; Troost D; Rozemuller-Kwakkel JM
Acta Neuropathol; 2005 Apr; 109(4):433-42. PubMed ID: 15714316
[TBL] [Abstract][Full Text] [Related]
8. [Congenital disorder of type Ia protein glycosylation: clinical, biochemical and molecular characteristics in 2 siblings with cerebellar hypoplasia].
Honzík T; Malonová E; Hansíková H; Rosipal R; Poupĕtová H; Martásek P; Zeman J
Cas Lek Cesk; 2003; 142(5):276-9. PubMed ID: 12920791
[TBL] [Abstract][Full Text] [Related]
9. Congenital disorders of glycosylation type Ia and Ib. Genetic, biochemical and clinical studies.
Kjaergaard S
Dan Med Bull; 2004 Nov; 51(4):350-63. PubMed ID: 16009061
[No Abstract] [Full Text] [Related]
10. PMM2 intronic branch-site mutations in CDG-Ia.
Vuillaumier-Barrot S; Le Bizec C; De Lonlay P; Madinier-Chappat N; Barnier A; Dupré T; Durand G; Seta N
Mol Genet Metab; 2006 Apr; 87(4):337-40. PubMed ID: 16376131
[TBL] [Abstract][Full Text] [Related]
11. Phosphomannomutase deficiency: the molecular basis of the classical Jaeken syndrome (CDGS type Ia).
Matthijs G; Schollen E; Heykants L; Grünewald S
Mol Genet Metab; 1999 Oct; 68(2):220-6. PubMed ID: 10527672
[No Abstract] [Full Text] [Related]
12. Characterization of two unusual truncating PMM2 mutations in two CDG-Ia patients.
Schollen E; Keldermans L; Foulquier F; Briones P; Chabas A; Sánchez-Valverde F; Adamowicz M; Pronicka E; Wevers R; Matthijs G
Mol Genet Metab; 2007 Apr; 90(4):408-13. PubMed ID: 17307006
[TBL] [Abstract][Full Text] [Related]
13. Hydrophobic Man-1-P derivatives correct abnormal glycosylation in Type I congenital disorder of glycosylation fibroblasts.
Eklund EA; Merbouh N; Ichikawa M; Nishikawa A; Clima JM; Dorman JA; Norberg T; Freeze HH
Glycobiology; 2005 Nov; 15(11):1084-93. PubMed ID: 16079417
[TBL] [Abstract][Full Text] [Related]
14. PMM2 mutation spectrum, including 10 novel mutations, in a large CDG type 1A family material with a focus on Scandinavian families.
Bjursell C; Erlandson A; Nordling M; Nilsson S; Wahlström J; Stibler H; Kristiansson B; Martinsson T
Hum Mutat; 2000 Nov; 16(5):395-400. PubMed ID: 11058896
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the 415G>A (E139K) PMM2 mutation in carbohydrate-deficient glycoprotein syndrome type Ia disrupting a splicing enhancer resulting in exon 5 skipping.
Vuillaumier-Barrot S; Barnier A; Cuer M; Durand G; Grandchamp B; Seta N
Hum Mutat; 1999 Dec; 14(6):543-4. PubMed ID: 10571956
[TBL] [Abstract][Full Text] [Related]
16. Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia).
Matthijs G; Schollen E; Bjursell C; Erlandson A; Freeze H; Imtiaz F; Kjaergaard S; Martinsson T; Schwartz M; Seta N; Vuillaumier-Barrot S; Westphal V; Winchester B
Hum Mutat; 2000 Nov; 16(5):386-94. PubMed ID: 11058895
[TBL] [Abstract][Full Text] [Related]
17. Neurological presentation in pediatric patients with congenital disorders of glycosylation type Ia.
Miossec-Chauvet E; Mikaeloff Y; Heron D; Merzoug V; Cormier-Daire V; de Lonlay P; Matthijs G; Van Hulle C; Ponsot G; Seta N
Neuropediatrics; 2003 Feb; 34(1):1-6. PubMed ID: 12690561
[TBL] [Abstract][Full Text] [Related]
18. Clinical features in adults with congenital disorders of glycosylation type Ia (CDG-Ia).
Krasnewich D; O'Brien K; Sparks S
Am J Med Genet C Semin Med Genet; 2007 Aug; 145C(3):302-6. PubMed ID: 17639595
[TBL] [Abstract][Full Text] [Related]
19. [Skin manifestations of protein glycosylation deficiency, the CDG (carbohydrate deficient glycoprotein) type 1 syndrome].
Vabres P; Sevin C; Amoric JC; Odièvre MH; Saudubray JM; de Prost Y
Ann Dermatol Venereol; 1998 Oct; 125(10):715-6. PubMed ID: 9835963
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous findings in congenital disorders of glycosylation: the hanging fat sign.
Dyer JA; Winters CJ; Chamlin SL
Pediatr Dermatol; 2005; 22(5):457-60. PubMed ID: 16191002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
